688217 Shanghai Rightongene Biotechnology
- 17.83
- +0.53+3.06%
Shanghai Rightongene Biotechnology News
Legal Opinion of Shanghai AllBright Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Shanghai Ruiang Gene Technology Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Ruian Gene
Ruian Gene 2024 Second Extraordinary General Meeting of Shareholders Meeting Information
Rayon Gene\'s announcement on the appointment of a representative for securities affairs
Announcement of Ruion Genomics on preparation for asset impairment for the semi-annual calculation of 2024
Announcement of Ruion Genomics on terminating the issuance of convertible corporate bonds to unspecified targets
Notice of Ruian Gene on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement by R&K Genes regarding the change of name and registered address of shareholders holding more than 5% of the company's shares and completion of business registration changes.
Announcement of Rayone Genetics on the establishment of a fund-raising special account by its wholly-owned subsidiary and the signing of a quadrilateral supervision agreement for the storage of fund-raising special accounts.
Announcement of Ruiang Gene's Resignation of Securities Affairs Representative.
Announcement from Ruiang Gene about voluntary disclosure of its wholly-owned subsidiary obtaining a registration certificate for medical instruments.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Ruian Gene
Legal Opinion of Shanghai AllBright Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Ruian Gene Technology Co., Ltd.
Ruian Gene 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Ruion Genomics on preparations for the impairment of assets transferred back to the first quarter of 2024
Announcement of Ruian Gene on increasing the number of implementing entities for some fund-raising projects, postponing and adjusting the internal investment structure of some fund-raising projects
Announcement of Ruian Genomics requesting the shareholders' meeting to authorize the board of directors to issue shares to specific targets through simple procedures
Announcement of Ruian Gene on the 2024 Remuneration Plan for Directors, Supervisors and Senior Managers
Announcement of Ruion Genetics on amending the “Articles of Association” and some internal management systems
Announcement of Ruion Genetics on the use of some temporarily idle funds for cash management
Analysis
Price Target
No Data
No Data